Novartis Investigative Site

Bengbu 233004

0 studies enrolling now · 3 studies all time

What they study most

Autoimmunity, Inflammation, Osteoarthritis, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis — Stopped early